Acute Coronary Syndromes (ACS) encompasses a range of conditions associated with sudden, reduced blood flow to the heart. This includes unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). Understanding the differences, diagnosis, and management of these conditions is crucial for the PLAB exam.
| Type | Description | ECG Findings | Biomarkers |
|---|---|---|---|
| Unstable Angina | Reduced blood flow causing chest pain, no myocardial damage | Normal or non-specific changes | Normal |
| NSTEMI | Myocardial infarction without ST elevation | ST depression, T wave inversion | Elevated (Troponin, CK-MB) |
| STEMI | Myocardial infarction with ST elevation | ST elevation in contiguous leads | Elevated (Troponin, CK-MB) |
| Phase | Treatment |
|---|---|
| Initial Management | – Oxygen if hypoxic<br>- Nitrates (GTN)<br>- Aspirin<br>- Morphine for pain relief |
| Antiplatelet Therapy | – Dual antiplatelet therapy (DAPT): Aspirin + P2Y12 inhibitor (e.g., clopidogrel) |
| Anticoagulation | – Heparin or LMWH (Low Molecular Weight Heparin) |
| Reperfusion Therapy | – STEMI: Primary PCI (Percutaneous Coronary Intervention) within 90 minutes or thrombolysis if PCI not available.<br>- NSTEMI/Unstable Angina: Risk stratify using scores like GRACE to decide on early invasive vs. conservative management. |
| Beta-blockers | – To reduce myocardial oxygen demand |
| Statins | – High-intensity statins for secondary prevention |
| ACE Inhibitors | – For patients with left ventricular dysfunction, hypertension, or diabetes |